Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FN +10.1% (also increases buyback authorization), AS +7.7%, FLXS +4.6%, NMM +3.5%, PANW +2.4% (also adds $500 mln to buyback plan), XPEV +0.8%, MDT +0.6%, FUTU +0.5%, LOW +0.5%
Other news:
- BTBT +13.4% (signs binding term sheet with Boosteroid)
- LNZA +1.4% (LanzaTech and LanzaJet Announce New Project with Wagner Sustainable Fuels in Australia)
- ELAN +1.3% (FDA has completed its review of all major and minor technical sections for Credelio Quattro, and the final 60-day administrative review is underway)
- MNST +0.9% (authorizes new $500 mln repurchase plan)
Analyst comments:
- BAK +3.2% (upgraded to Buy from Neutral at Citigroup)
- AR +1.6% (upgraded to Sector Outperform from Sector Perform at Scotiabank)
- BMRN +1.3% (upgraded to Outperform from Mkt Perform at Bernstein)